Dr Gerald Yong is an interventional cardiologist who has an interest in coronary artery disease, structural/valvular heart disease, coronary angioplasty and stenting, percutaneous closure of cardiac defects, percutaneous closure of prosthetic paravalvul Read More...

Procedures & Conditions

Procedures Performed
  • Transcatheter Aortic Valve Implantation (TAVI)
  • Transcatheter Pulmonary Valve Implantation
  • Closure of Atrial Septal Defects
  • Paravalvular Regurgitation of Prosthetic Heart Valve
  • Percutaneous Aortic Valve Replacement
  • Balloon Aortic Valvuloplasty
  • Percutaneous Mitral Commissurotomy
  • Stenting of Coarctation of Aorta
  • Pulmonic Valvuloplasty
  • Diagnostic / Therapeutic Catheterizations of Adult Patients with Complex Congenital Heart Disease.
Conditions Treated
  • Aortic Stenosis
  • Structural Heart Disease
  • Valvular Heart Diseases
  • Adult Congenital Heart Disease


  • Director of Structural Heart Intervention
    Fiona Stanley Hospital 2013 - Present
  • Consultant Interventional Cardiologist
    Fiona Stanley Hospital 2013 - Present
  • Consultant Interventional Cardiologist
    Wexford Medical Centre Present
  • Locum Interventional Cardiologist
    Fiona Stanley Hospital 2008 - 2013
  • Interventional Fellow in Cardiology
    Montreal Heart Institute 2007 - 2008
  • Interventional Fellow in Cardiology
    Evanston Hospital 2006 - 2007
  • Locum Consultant Physician
    Kalgoolie Regional Hospital 2006
  • Interventional Fellow in Cardiology
    Royal Perth Hospital 2004 - 2006


  • 2008

    7th International Pulmonary Hypertension Forum Poster Award

  • Royal Perth Hospital Medical Research Foundation Young Investigators Day Hospital Clinical Award

Research & Publications


1. Ihdayhid, A. R., Asrar Ul Haq, M., Dembo, L. and Yong, G. Simultaneous Coronary and Pulmonary Angiography to Diagnose Critical Left Main Coronary Artery Stenosis Secondary to Dilated Pulmonary Artery JACC Cardiovasc Interv 2016;9:1193-4

2. Reny, J. L., Fontana, P., Hochholzer, W., Neumann, F. J., Ten Berg, J., Janssen, P. W., Geisler, T., Gawaz, M., Marcucci, R., Gori, A. M., Cuisset, T., Alessi, M. C., Berdague, P., Gurbel, P. A., Yong, G., Angiolillo, D. J., Aradi, D., Beigel, R., Campo, G. and Combescure, C. Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data Thromb Haemost 2016;115:844-55

3. Dunne B, Tan D, Chu D, Yau V, Xiao J, Ho KM, Yong G, Larbalestier R. Transapical versus transaortic transcatheter aortic valve implantation: A systematic review. Ann Thorac Surg. 2015;100:354-361

4. Meredith IT, Walton A, Walters DL, Pasupati S, Muller DW, Worthley SG, Yong G, Whitbourn R, Duffy SJ, Ormiston J. Mid-term outcomes in patients following transcatheter aortic valve implantation in the corevalve australia and new zealand study. Heart Lung Circ. 2015;24:281-290

5. Putrino AL, Best M, Yong G. Improved quality of life two-years post transcatheter aortic valve replacement for a regurgitant aortic homograft. Heart Lung Circ. 2015;24:e51-55

6. Walters DL, Sinhal A, Baron D, Pasupati S, Thambar S, Yong G, Jepson N, Bhindi R, Bennetts J, Larbalestier R, Clarke A, Brady P, Wolfenden H, James A, El Gamel A, Jansz P, Chew DP, investigators SA. Initial experience with the balloon expandable edwards-sapien transcatheter heart valve in australia and new zealand: The source anz registry: Outcomes at 30 days and one year. Int J Cardiol. 2014;170:406-412

7. Nuis RJ, Sinning JM, Rodes-Cabau J, Gotzmann M, van Garsse L, Kefer J, Bosmans J, Yong G, Dager AE, Revilla-Orodea A, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Amat-Santos IJ, Lopez J, Dumont E, van Mieghem N, van Gelder T, van Domburg RT, de Jaegere PP. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6:625-634

8. Mwipatayi BP, Picardo A, Masilonyane-Jones TV, Larbalestier R, Thomas S, Turner J, Vijayan V, Yong G. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. J Vasc Surg. 2013;58:1028-1036 e1021

9. Yeow WL, Roberts-Thomson P, Shetty S, Yong G. Expanding role for transcatheter aortic valve replacement: Successful transfemoral implantation of a medtronic corevalve for severe aortic regurgitation. Heart Lung Circ. 2012;21:754-758

10. Kong WY, Yong G, Irish A. Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology. 2012;17:445-451

11. Yeow WL, Dembo L, Aithal J, Yong G, Clugston R. Internal mammary artery graft fistulae to the pulmonary arteries as a cause of myocardial ischaemia after coronary artery bypass graft. Heart Lung Circ. 2012;21:249-250

12. Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, Yong G, Gattorna T, Paul V. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012;79:794-800

13. Yeow WL, Edwards M, Yong G. Perioperative rupture of the lima graft leading to cardiogenic shock, emergency angiography, and stenting with a polytetrafluoroethylene-covered stent. Catheter Cardiovasc Interv. 2012;79:640-643

14. Tay EL, Gurvitch R, Wijeysinghe N, Nietlispach F, Leipsic J, Wood DA, Yong G, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv. 2011;4:228-234

15. Lam YY, Lee PW, Yong G, Yan BP. Investigational devices for mitral regurgitation: State of the art. Expert Rev Med Devices. 2011;8:105-114

16. Yong G, Ali A, Feldman T. Diastolic transmitral valve pressure gradients in patients with severe calcific aortic stenosis. Catheter Cardiovasc Interv. 2009;74:957-964.

17. Yong G, Khairy P, De Guise P, Dore A, Marcotte F, Mercier L-A, Noble S, Ibrahim R. Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study. Circ Cardiovasc Interv. 2009;2:455-462.

18. Noble S, Miró J, Yong G, Bonan R, Tardif JC, Ibrahim R. Rapid Pacing Rotational Angiography with Three-Dimensional Reconstruction: Use and Benefits in Structural Heart Disease Interventions. EuroIntervention 2009;5:244-249

19. Pearson L, Thom J, Adams M, Oostryck R, Krueger R, Yong G, Baker R. A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol. 2009;31:430-439.

20. Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, Chew DP, Dick R, Eccleston D, Hockings B, Walters D, Whelan A, Eikelboom JW. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial. Am Heart J. 2009;157(1):60 e61-69.

21. Yong G, Hayes H, O’Driscoll G. Strategy of aggressive steroid weaning and routine alendronate therapy to reduce bone loss after cardiac transplantation. Transplant Proc. 2007;39(10):3340-3343.

22. Feldman T, Yong G. Right Heart Catheterization from the Femoral Route. Cardiac Interventions Today. 2007;Sept 2007:62

23. Yong G, Sanborn T. Percutaneous Coronary Intervention for Bifurcation Disease: Current techniques and future technologies. Cardiac Interventions Today. 2007;Sept 2007:56-61.

24. Yong G, Salinger MH, Feldman T. Device closure for PFO: The data and devices associated with percutaneous PFO closure. Cardiac Interventions Today. 2007;June 2007:32-40.

25. Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol. 2007;102(11):2411-2416.

26. Walsh JH, Yong G, Cheetham C, Watts GF, O’Driscoll GJ, Taylor RR, Green DJ. Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J. 2003;24(18):1681-1689.

View More

Related Articles

LATEST IN Accredited TAVI Practitioner

Heart disease is often a complex and overwhelming topic. Dr…

LATEST IN Accredited TAVI Practitioner

The Benefits and Risks of an Angioplasty Procedure The coronary…

LATEST IN Accredited TAVI Practitioner

What is Heart Disease? Heart Disease is also known as…